RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $513,000 | -35.7% | 93,139 | +12.9% | 0.00% | – |
| Q4 2021 | $798,000 | -25.7% | 82,511 | +37.4% | 0.00% | – |
| Q3 2021 | $1,074,000 | -17.4% | 60,058 | +12.8% | 0.00% | – |
| Q2 2021 | $1,300,000 | +1.3% | 53,261 | +10.0% | 0.00% | – |
| Q1 2021 | $1,283,000 | +51.3% | 48,423 | -56.7% | 0.00% | – |
| Q4 2020 | $848,000 | +24.7% | 111,804 | -17.5% | 0.00% | – |
| Q3 2020 | $680,000 | -16.3% | 135,580 | -0.1% | 0.00% | – |
| Q2 2020 | $812,000 | +57.1% | 135,665 | +17.0% | 0.00% | – |
| Q1 2020 | $517,000 | -52.4% | 115,954 | +1.4% | 0.00% | – |
| Q4 2019 | $1,087,000 | +61.8% | 114,371 | +33.7% | 0.00% | – |
| Q3 2019 | $672,000 | -68.2% | 85,530 | -36.3% | 0.00% | -100.0% |
| Q2 2019 | $2,111,000 | +16.5% | 134,211 | +34.0% | 0.00% | 0.0% |
| Q1 2019 | $1,812,000 | +558.9% | 100,131 | +485.6% | 0.00% | – |
| Q4 2018 | $275,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |